0RHR.LSE Kuros Biosciences Ltd.

Healthcare Oil, Gas & Consumable Fuels London Exchange
33.51 GBP
Close of Nov 3, 2026
16.46 32.48
Market cap
GBP 275M
P/E
-
P/B
-
ROE
19.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 0RHR.LSE undervalued?

Graham number

The Graham number of Kuros Biosciences Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kuros Biosciences Ltd. fundamental analysis

No fundamental analysis for Kuros Biosciences Ltd. yet.

Kuros Biosciences Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kuros Biosciences Ltd.

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or po…

Full company profile